Prospective identification of tumorigenic breast cancer cells
Howard Hughes Medical Institute · University of Michigan
Abstract
Breast cancer is the most common malignancy in United States women, accounting for >40,000 deaths each year. These breast tumors are comprised of phenotypically diverse populations of breast cancer cells. Using a model in which human breast cancer cells were grown in immunocompromised mice, we found that only a minority of breast cancer cells had the ability to form new tumors. We were able to distinguish the tumorigenic (tumor initiating) from the nontumorigenic cancer cells based on cell surface marker expression. We prospectively identified and isolated the tumorigenic cells as CD44(+)CD24(-/low)Lineage(-) in eight of nine patients. As few as 100 cells with this phenotype were able to form tumors in mice,…
Citation impact
- FWCI
- 69.74
- Percentile
- 100%
- References
- 38
Authors
5- MAMuhammad Al‐HajjCorresponding
Howard Hughes Medical Institute, University of Michigan
- MSMax S. Wicha
Howard Hughes Medical Institute, University of Michigan
- ABAdalberto Benito‐Hernández
Howard Hughes Medical Institute, University of Michigan
- SJSean J. Morrison
Howard Hughes Medical Institute, University of Michigan
- MFMichael F. Clarke
Howard Hughes Medical Institute, University of Michigan
Topics & keywords
- CD44
- CD24
- Breast cancer
- Cancer research
- Cancer
- Cancer stem cell
- Biology
- Malignancy
- Good health and well-being